Examination of minimum invasive surgery combined method with trans-oral resection and sentinel lymph node biopsy using an indocyanine green fluorescence in laryngo-pharyngeal cancer patients

Examination of minimum invasive surgery combined method with trans-oral resection and sentinel lymph node biopsy using an indocyanine green fluorescence in laryngo-pharyngeal cancer patients - Examination of combined method with trans-oral resection and sentinel lymph node biopsy using an indocyanine green fluorescence in laryngo-pharyngeal cancer patients

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000009671

Enrollment

Registered

2013-01-05

Start date

2013-01-05

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pharyngo-laryngeal cancer

Interventions

Sentinel node lymph node biopsy metastasis in head and neck cancer patients using an ICG fluorescence method

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1)Previously untreated and clinically negative neck laryngo-pharyngeal (T1-T2) squamous cell carcinoma patients are the candidates for our study. 2)Patient age 20 years and above. 3)Patients who were provided written informed consent.

Exclusion criteria

Exclusion criteria: 1)Previously treated patients 2)A history of radiation therapy for the neck 3)Pregnancy or lactating women, or women with suspected pregnancy 4)Patient judged by the investigator to be unfit to be enrolled into the study

Design outcomes

Primary

Measure	Time frame
Positivity of lymph node metastasis	—

Secondary

Measure	Time frame
Accuracy of detecting of sentinel nodes Range of disease free survival	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026